EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Glycerol Inhibition of Lactose‐Supported Growth and Lactose‐Driven Transcriptional Reprogramming in Streptococcus pyogenes

Ayako Bando, Yujiro Hirose, Olivia M. Bertolla, Norihiko Takemoto, Stephan Brouwer, Jack O′Donohue, Masayuki Ono, Eri Ikeda, Victor Nizet, Mark J. Walker, Shigetada Kawabata

International Journal of Microbiology · 2026-01 · 2026 (1)

DOI: 10.1155/ijm/7188836 ↗
AbstractBibliografische Angaben

Abstract

Streptococcus pyogenes (Group A Streptococcus [GAS]) requires flexible metabolic regulation to adapt to diverse host environments; however, its physiological responses to lactose and glycerol remain poorly characterized compared with glucose. In this study, we analyzed three representative serotype M1 GAS strains—the M1 global strain 5448, the ancestral M1 strain SF370, and SP1380 as a representative of the recently emerged M1 UK lineage. Glycerol consistently suppressed lactose‐dependent growth across all strains, whereas glycerol‐dependent respiratory activity was observed in 5448 and SF370 but was absent in SP1380. RNA‐seq analysis of strain 5448 revealed no significant transcriptional changes upon glycerol supplementation, indicating that this inhibitory effect likely occurs through a nontranscriptional mechanism. In contrast, lactose supplementation induced distinct transcriptional programs compared with glucose, including coordinated expression changes gene sets regulated by carbohydrate‐responsive transcription factors (CcpA, MalR, and NanR) and by the virulence regulator Mga and the stress‐response regulator Rgg. Together, these findings identify a previously unrecognized layer of carbon source‐dependent metabolic regulation and growth control in GAS.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →